Interestingly, elevated RIPK1 levels in PPMS patients correlated with the loss of myelin basic protein (MBP) expression, suggesting increased demyelination may be linked to RIPK1 activation (Figures S1A and S1B). The gene discussed is MBP; the disease is primary progressive multiple sclerosis.